Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems

Advanced Drug Delivery Reviews

Volumn 49, Issue 1-2, 2001, Pages 127-149

  Weissig, Volkmar ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Bolasomes; Cationic lipids; Dequalinium; DQAsomes; Mitochondrial diseases; Mitochondrial gene therapy; Mitochondrial transfection vector; Non viral DNA delivery

Indexed keywords

BIOCHEMISTRY; DISEASES; DNA; DRUG THERAPY; GENES; METABOLISM; RESPIRATORY SYSTEM;

MITOCHONDRIAL GENOME;

GENETIC ENGINEERING;

AMPHOPHILE; DEQUALINIUM; DRUG CARRIER;

AEROBIC METABOLISM; CHEMICAL STRUCTURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DELIVERY SYSTEM; GENE THERAPY; GENETIC DISORDER; GENETIC TRANSFECTION; HUMAN; MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RESPIRATORY CHAIN; REVIEW;

EID: 0035797116     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00131-4     Document Type: Article

References (100)

1. Preface
2. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy
3. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
4. Mitochondrial diseases and aging
5. Mitochondrial diseases in man and mouse
6. Human mitochondrial DNA diseases
7. Gene therapy for mitochondrial DNA defects: Is it possible?
8. Towards mitochondrial gene therapy: DQAsomes as a strategy
9. Pharmaceutical approach to somatic gene therapy
10. Different genetic code in human mitochondria
11. Apparent functional independence of the mitochondrial and nuclear transcription systems in cultured human cells
12. Import of RNA into mitochondria
13. Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm
14. RNA delivery into mitochondria
15. Evolutionary origin of mitochondria
16. Recombinant adeno-associated virus-based gene transfer for defects in oxidative metabolism
17. Mitochondrial gene therapy: An arena for the biomedical use of inteins
18. Structural similarities between a mitochondrially encoded polypeptide and a family of prokaryotic respiratory toxins involved in plasmid maintenance suggest a novel mechanism for the evolutionary maintenance of mitochondrial DNA
19. Liposomes injected intravenously into mice associate with liver mitochondria
20. Intracellular fate of liposome-encapsulated DNA in mouse liver. Analysis using electron microscope autoradiography and subcellular fractionation
21. Interaction of intravenously injected liposomes with mouse liver mitochondria. A fluorescence and electron microscopy study
22. Proteoliposomes colocalized with endogenous mitochondria in mouse fertilized egg
23. Organelle transformation: Shoot first, ask questions later
24. Introduction of plasmid DNA into isolated mitochondria by electroporation. A novel approach towards gene correction for mitochondrial disorders
25. Insertion of an exogenous gene into the mouse mitochondrial genome by homologous recombination in yeast
26. Towards gene therapy of mitochondrial disorders
27. Gene therapy of mitochondrial diseases using human cytoplasts
28. Gene therapy by mitochondrial transfer
29. Targeting of proteins to mitochondria
30. Protein translocation pathways of the mitochondrion
31. DNA-protein conjugates can enter mitochondria via the protein import pathway
32. Transfection of mitochondria: Strategy towards a gene therapy of mitochondrial DNA diseases
33. Processing of artificial peptide-DNA conjugates by the mitochondrial intermediate peptidase
34. Peptide nucleic acid delivery to human mitochondria
35. An antigenomic strategy for treating heteroplasmic mtDNA disorders
36. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids
37. Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism
38. Slip and leak in mitochondrial oxidative phosphorylation
39. Drug delivery to mitochondria: The key to mitochondrial medicine
40. The influence of respiration and ATP hydrolysis on the proton-electrochemical gradient across the inner membrane of rat liver mitochondria as determined by ion distribution
41. Use of fluorescent probes to monitor mitochondrial membrane potential in isolated mitochondria, cell suspensions, and cultured cells
42. Selective targeting of bioactive compounds to mitochondria
43. Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria
44. Probing mitochondria in living cells with rhodamine 123
45. Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells
46. GRP78 Induction by calcium ionophore potentiates photodynamic therapy using the mitochondrial targeting dye Victoria Blue BO
47. Abnormal DNA patterns in animal mitochondria: Ethidium bromide-induced breakdown of circular DNA and conditions leading to oligomer accumulation
48. Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation
49. Phosphonium salts exhibiting selective anti-carcinoma activity in vitro
50. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells
51. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines
52. Antineoplastic activity, synergism, and antagonism of triarylalkylphosphonium salts and their combinations
53. Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride
54. Self-assembling drugs: A new approach to biochemical modulation in cancer chemotherapy
55. Effect of hypoxia and acidosis on the cytotoxicity of six metal(ligand)4(rhodamine-123)2 complexes at normal and hyperthermic temperature
56. GRP78 Induction by calcium ionophore potentiates photodynamic therapy using the mitochondrial targeting dye Victoria Blue BO
57. Induction of mitochondrial dysfunction and apoptosis in HeLa cells by bis-pyridinium oximes, a newly synthesized family of lipophilic biscations
58. Effects of the lipophilic biscation, bis-pyridinium oxime BP12, on bioenergetics and induction of permeability transition in isolated mitochondria
59. Targeting large molecules to mitochondria
60. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
61. Letter to the editor
62. Cationic amphiphiles as delivery systems for genes into eukaryotic cells
63. Biological barriers to gene delivery
64. The emergence of clathrin-independent pathways
65. Cellular and molecular barriers to gene transfer by a cationic lipid
66. Genetic vaccines: Strategies for optimization
67. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection
68. Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells
69. Induction of apoptosis in macrophages by cationic liposomes
70. Induction of apoptosis in WEHI 231 cells by cationic liposomes
71. Induction of apoptosis in macrophages by cationic liposomes
72. Polyelectrolyte effects in DNA condensation by polyamines
73. Condensation of DNA by multivalent cations: Consideration on mechanism
74. Dna packaging in non-viral systems
75. Cationic liposome-mediated transfection
76. Liposomes as agents of DNA transfer
77. New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy
78. DNA packaging induced by micellar aggregates: A novel in vitro condensation system
79. An electron microscopy study into the mechanism of gene transfer with lipopolyamines
80. Monomolecular collapse of plasmid DNA into stable virus-like particles
81. Template oligomerization of DNA-bound cations produces calibrated nanometric particles
82. Structure, biosynthesis, and physicochemical properties of archaebacterial lipids
83. Archaeal lipids and their biotechnological applications
84. Cationic single-chain bolaamphiphiles as new materials for applications in medicine and biotechnology
85. Micellar properties and surface activity of some bolaform drugs in aqueous solution
86. Computer simulations of DQAsomes
87. DQAsomes: A novel potential drug and gene delivery system made from dequalinium™
88. DNA binding cationic bolasomes with delocalized charge center: A structure-activity relationship study
89. Mitochondriotropic cationic vesicles: A strategy towards mitochondrial gene therapy
90. Bolaamphiphile dequalinium™ vesicles and their stable complexes with DNA which are protected from Dnase attack
91. Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes
92. Micellar delivery system for dequalinium - A lipophilic cationic drug with anticarcinoma activity
93. Assembly of functional proton-translocating ATPase complex in yeast mitochondria with cytoplasmically synthesized subunit 8, a polypeptide normally encoded within the organelle